Variant report
Variant | nsv892823 |
---|---|
Chromosome Location | chr9:25298264-25349769 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs527359532 | chr9:25310807-25310808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529343269 | chr9:25310815-25310816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115900249 | chr9:25310832-25310833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547156383 | chr9:25310874-25310875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568603637 | chr9:25310886-25310887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs369878141 | chr9:25310893-25310894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145313294 | chr9:25310907-25310908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs10757519 | chr9:25310965-25310966 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs181711899 | chr9:25310967-25310968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200714620 | chr9:25310996-25310997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571470130 | chr9:25311033-25311034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs527489289 | chr9:25311037-25311038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs187134698 | chr9:25311060-25311061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1627269 | chr9:25311064-25311065 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs536333694 | chr9:25311108-25311109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556231073 | chr9:25311184-25311185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs147188748 | chr9:25311194-25311195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538600817 | chr9:25311254-25311255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs539860967 | chr9:25311259-25311260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs10812220 | chr9:25311297-25311298 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs578189222 | chr9:25311307-25311308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs140550108 | chr9:25311334-25311335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553924561 | chr9:25311363-25311364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573830237 | chr9:25311397-25311398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs542727285 | chr9:25311402-25311403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190835814 | chr9:25311403-25311404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs531608786 | chr9:25311414-25311415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs75672392 | chr9:25311422-25311423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs565077810 | chr9:25311437-25311438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs527583433 | chr9:25311442-25311443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1751816 | chr9:25311467-25311468 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs567455042 | chr9:25311484-25311485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529882045 | chr9:25311500-25311501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549633184 | chr9:25311555-25311556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs569686483 | chr9:25311566-25311567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs373360993 | chr9:25311615-25311616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs144719284 | chr9:25311629-25311630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs61426218 | chr9:25311632-25311633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs571634867 | chr9:25311680-25311681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs145762650 | chr9:25311718-25311719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs118033886 | chr9:25311724-25311725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs375887714 | chr9:25311801-25311802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs573916755 | chr9:25311808-25311809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs1348328 | chr9:25311842-25311843 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs1751815 | chr9:25311850-25311851 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs12685037 | chr9:25311859-25311860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576468971 | chr9:25311864-25311865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs74582812 | chr9:25311885-25311886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540690014 | chr9:25311886-25311887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs148918159 | chr9:25311929-25311930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Lung cancer | 21911935 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
head and neck squamous cell carcinoma | 21798897 | CNVD |
Cancer | 21253487 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Leukemia | 19602459 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21364760 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Lung cancer | 21569311 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:25310800-25312000 | Enhancers | Fetal Brain Male | brain |
2 | chr9:25311000-25311400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
3 | chr9:25311000-25311400 | Enhancers | Adipose Nuclei | Adipose |
4 | chr9:25323400-25323800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr9:25323800-25325400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
6 | chr9:25325400-25325600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr9:25325600-25326000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
8 | chr9:25325800-25326200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr9:25325800-25326200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
10 | chr9:25326000-25326400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr9:25334400-25334600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr9:25347200-25348400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |